Tim Cowper is a Chartered Accountant and Operations specialist who has worked across a range of life science/healthcare companies in the UK and US, both private and public companies. These include Celltech, Vernalis/British Biotech, Bioventix and Sterilox. Qualified as an Accountant at Ernst &a; Young (Ernst &a; Whinney), Tim has directed companies in their financial management and also through transactions including M&a;A, reorganisations and IPOs. Tim joined Oxford Nanopore in a financial and operations role in 2012 and oversees the financial team as well as strategic supply chain operations. Tim is a keen sailor and was also Finance Director of Clipper Ventures.
Tim Cowper is a highly experienced Chartered Accountant and Operations specialist with 37.9 years of work experience. He has worked across various life science/healthcare companies in the UK and the US, both private and public. Tim has directed companies in financial management and transactions, including M&A, reorganisations, and IPOs. He has also held positions at Oxford Nanopore, The CFO Centre UK, and Clipper Ventures. Tim is known for his expertise in medical devices and operations. He is based in the United Kingdom.
The CFO Centre is the world's number 1 provider of part-time Chief Financial Officers to SMEs with over 450 CFOs operating out of 70+ offices across 5 continents and managing a combined turnover of £5 billion. Ambitious £2m - £50m turnover companies are able to have one of the country's top Finance Directors working at their business but uniquely, on a part-time basis. This means that companies which do not require a full-time FD (or would prefer not to pay a full time salary) can leverage the skills of a senior part-time FD for a fraction of the cost. In addition to this, the FD Centre operates a unique 'Team' structure. With over 100 part-time FDs across the UK, we have an unparalleled combined skill set which each of our client can leverage... What do we mean by this? As an example, if one of our clients is wanting to sell their business, instead of just having one FD working on the sale, our 'Team' structure means that we can collaborate quickly across our entire group of FDs not only to help maximise the equity value of the business pre-sale but also in helping to find the ideal buyer, willing to pay the highest price. This is just one example. We do in fact help businesses across a wide range of functions including: - Strategy and exit planning - Risk management - Business planning - Funding - Internal controls - Reporting - Profit improvement - Cash flow management - Compliance - Tax planning and legal issues - Outsourcing - Banking relationship In addition to our UK team we also have offices in Australia, South Africa, Canada, Singapore, Netherlands No recruitment fee
We develop and apply fragment and structure-based methods to solve problems in drug discovery, and have generated cell active lead compounds and development candidates against targets in oncology, neurodegeneration, anti-infectives and inflammation. Our established group of experienced scientists is based at our fully-equipped research laboratories on Granta Park, Cambridge UK. We integrate fragment-based approaches, structural biology, biophysics, assay technology and molecular modelling with extensive medicinal chemistry expertise to enable drug discovery on both established and novel targets. We have the experience and capabilities for progressing projects from target identification through to clinical candidate. We have generated lead compounds on kinases, ATPases, protein-protein interactions and GPCRs, leading to clinical candidates for Chk1, Hsp90, Bcl-2, Mcl-1, FAAH and A2A. We balance an internal portfolio of drug discovery projects with fully integrated research collaborations on targets with pharmaceutical companies and academic partners. Our shared-risk approach ensures a high level of engagement from our scientists and rewards success. Current disclosed collaborations include those with Servier, Daiichi Sankyo, Lundbeck and Asahi Kasei Pharma, and we seek additional partnerships.
EY exists to build a better working world, helping create long-term value for clients, people and society and build trust in the capital markets. Enabled by data and technology, diverse EY teams in over 150 countries provide trust through assurance and help clients grow, transform and operate. Working across assurance, consulting, law, strategy, tax and transactions, EY teams ask better questions to find new answers for the complex issues facing our world today. Find out more about the EY global network http://ey.com/en_gl/legal-statement
We found 3 Tim Cowper's email addresses
We found 1 Tim Cowper's phone numbers
Tim Cowper's social media include: Linkedin,
Tim Cowper works for Oxford Nanopore Technologies
Tim Cowper's role in Oxford Nanopore Technologies is Chief Financial Officer
Tim Cowper's latest job experience is Chief Financial Officer at Oxford Nanopore Technologies
Tim Cowper's latest education in University of Sussex